{"gene":"MSL2","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":1995,"finding":"MSL2 (male-specific lethal-2) is a RING finger protein required for X chromosome dosage compensation in Drosophila males; it colocalizes with other MSL proteins on the male X chromosome and coimmunoprecipitates with MSL1 from male larval extracts, indicating it forms a dosage compensation protein complex. Ectopic expression of MSL2 in females causes assembly of the other MSL proteins on female X chromosomes, demonstrating MSL2 is the limiting/organizing subunit.","method":"Coimmunoprecipitation, ectopic expression in females, immunolocalization on polytene chromosomes","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP and functional ectopic expression, replicated across multiple labs","pmids":["7781064"],"is_preprint":false},{"year":1995,"finding":"MSL2 protein is not produced in females; sex-specific regulation is mediated through sequences in both the 5' and 3' UTRs of msl-2 mRNA, and msl-2 pre-mRNA is alternatively spliced in a Sex-lethal (SXL)-dependent fashion in its 5' UTR. MSL2 binding to the X chromosome requires the other three MSL proteins.","method":"Molecular cloning, reporter assays, polytene chromosome immunostaining in msl mutants","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, replicated by other labs","pmids":["7588059"],"is_preprint":false},{"year":1995,"finding":"MSL2, MSL1, and MLE are interdependent for sub-nuclear (X chromosome) localization beginning in early embryogenesis; loss of any one MSL protein abolishes the co-localization of the others and of histone H4Ac16 on the male X.","method":"Immunofluorescence on embryos, genetic loss-of-function","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with defined cellular phenotype, replicated","pmids":["8562424"],"is_preprint":false},{"year":1997,"finding":"SXL represses MSL2 protein production in females by acting synergistically through sequences in both the 5' and 3' UTRs of msl-2 mRNA, operating directly at the level of translation (not merely splicing).","method":"Reporter assays in vivo, genetic epistasis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — in vivo reporter assays with UTR deletions, replicated by other groups","pmids":["9182767"],"is_preprint":false},{"year":1998,"finding":"MSL1, MSL2, and MSL3 associate in a complex (by co-immunoprecipitation and chromatography); MSL2 interacts directly with MSL1 through residues clustered around the first zinc-binding site of the RING finger domain. Missense mutations in this region disrupt MSL2–MSL1 interaction and fail to support male viability. The MSL2 RING finger nucleates MSL complex assembly; MLE is only weakly/transiently associated.","method":"Yeast two-hybrid, Co-IP, chromatographic co-fractionation, site-directed mutagenesis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including mutagenesis, in vitro and in vivo validation","pmids":["9736618"],"is_preprint":false},{"year":1999,"finding":"SXL inhibits msl-2 splicing by binding the polypyrimidine tract of the regulated intron's 3' splice site, blocking U2AF65 binding and U2 snRNP recruitment. An unusually long distance between the poly(Y) tract and the AG dinucleotide is required. U2AF35 contacts the AG dinucleotide and stabilizes U2AF65 binding, and SXL can only displace U2AF65 when this U2AF35–AG interaction is weak.","method":"In vitro splicing assays, UV crosslinking, mutational analysis of splice sites","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro splicing with biochemical dissection, replicated","pmids":["10617208"],"is_preprint":false},{"year":1999,"finding":"SXL-mediated translational repression of msl-2 mRNA requires cooperation between SXL-binding sites in both the 5' and 3' UTRs and occurs by a poly(A) tail-independent mechanism, as demonstrated in a cell-free Drosophila embryo translation system.","method":"Cell-free translation system from Drosophila embryos, mutational analysis of UTRs","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro translation system with mechanistic dissection","pmids":["10545124"],"is_preprint":false},{"year":2001,"finding":"SXL inhibits msl-2 5' splice site recognition by binding a uridine-rich sequence downstream of the 5' splice site, preventing TIA-1 binding to that sequence and thereby blocking U1 snRNP recruitment. Combined with 3' splice site inhibition, SXL enforces intron retention via dual-site blockade.","method":"Psoralen crosslinking, in vitro splicing assays, UV-crosslinking, mutational analysis","journal":"RNA","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with biochemical mechanistic dissection","pmids":["11565743"],"is_preprint":false},{"year":2003,"finding":"SXL inhibits msl-2 mRNA translation initiation by preventing the stable association of the 40S ribosomal subunit with the mRNA; this requires SXL binding to both 5' and 3' UTRs and does not require a cap structure at the 5' end.","method":"In vitro translation assays, ribosome association assays (sucrose gradient), mutational analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with defined biochemical readout","pmids":["12769862"],"is_preprint":false},{"year":2003,"finding":"SXL acts as a translational repressor through its two RRM domains and a C-terminal heptapeptide extension; its repressor function is activated only when SXL binds msl-2 mRNA via its own RRMs. SXL recruits co-repressor proteins to the msl-2 3' UTR via sequences adjacent to its binding sites, and this requires an intact repressor domain.","method":"In vitro translation assays, UV-crosslinking, co-immunoprecipitation, tethering assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — multiple biochemical methods with mutational dissection","pmids":["14532129"],"is_preprint":false},{"year":2005,"finding":"The N-terminal leucine zipper-like motif of MSL1 directly binds MSL2, and the basic motif at the MSL1 N-terminus is required for X chromosome binding. A glycine-rich region mediates MSL1 self-association and association with the MSL complex assembled on the X chromosome.","method":"Yeast two-hybrid, in vitro binding, polytene chromosome immunostaining in mutants","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal binding assays combined with in vivo genetic validation","pmids":["16199870"],"is_preprint":false},{"year":2005,"finding":"MSL2 is stably (essentially immobile) associated with the X chromosome during interphase, as measured by photobleaching (FRAP) in living cells. Knockdown of MSL2 abolishes H4K16 acetylation and the twofold transcriptional elevation of the male X chromosome. Targeting MSL2 to a reporter gene is sufficient to initiate local dosage compensation.","method":"FRAP in living cells, RNAi knockdown, reporter gene tethering, transcription assays","journal":"Chromosoma","confidence":"High","confidence_rationale":"Tier 2 — direct FRAP localization with functional consequence, RNAi phenotype","pmids":["16179989"],"is_preprint":false},{"year":2006,"finding":"SXL recruits UNR (upstream of N-ras) to the msl-2 mRNA 3' UTR as a co-repressor; UNR is required for 3' UTR-mediated translational repression of msl-2, and SXL confers a female-specific function to the otherwise ubiquitous UNR protein.","method":"mRNP purification (mass spectrometry), co-immunoprecipitation, functional reporter assays, RNAi depletion","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — purification/MS identification with functional validation by RNAi","pmids":["16452508"],"is_preprint":false},{"year":2007,"finding":"The N-terminal RING finger domain of MSL2, in complex with MSL1, binds to the heterochromatic chromocenter and a few chromosomal arm sites. The carboxyl-terminal domain of MSL2 (proline-rich and basic motifs) is required for binding to hundreds of X-chromosomal sites and for efficient incorporation of roX RNAs into the MSL complex. Incorporation of roX RNAs alters the chromatin-binding specificity of the MSL1/MSL2 complex.","method":"GFP-fusion protein localization, domain deletion analysis, polytene chromosome immunostaining","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — systematic domain dissection with direct localization readout in vivo","pmids":["18086881"],"is_preprint":false},{"year":2009,"finding":"The SXL–UNR co-repressor complex inhibits ribosome recruitment to msl-2 mRNA via a PABP (poly(A)-binding protein)-dependent mechanism: efficient 3' UTR-mediated repression requires a poly(A) tail and PABP function, UNR directly interacts with PABP, and the repressor complex targets ribosome binding after PABP-mediated recruitment of eIF4E/G.","method":"In vitro translation assays, ribosome recruitment biochemical assays, protein-protein interaction assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with mechanistic dissection of translation initiation steps","pmids":["19941818"],"is_preprint":false},{"year":2010,"finding":"The CXC domain of MSL2 directly binds DNA with low nanomolar affinity in vitro. In vivo, the CXC domain is required for faithful targeting of the dosage compensation complex to the X chromosome; deletion of the CXC domain impairs DCC targeting in reporter assays and GFP-fusion localization experiments.","method":"Recombinant protein DNA-binding assay, reporter gene assay in vivo, GFP-fusion localization","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro biochemical DNA binding combined with in vivo functional validation","pmids":["20139418"],"is_preprint":false},{"year":2011,"finding":"Human MSL2, together with MSL1, functions as a histone E3 ubiquitin ligase that ubiquitylates nucleosomal H2B specifically on lysine 34 (H2B K34ub). H2B K34ub by MSL1/2 directly stimulates H3 K4 and K79 methylation through trans-tail crosstalk in vitro and in cells. This activity is important for transcription activation at HOXA9 and MEIS1 loci and is evolutionarily conserved in Drosophila.","method":"In vitro ubiquitylation assay with reconstituted nucleosomes, mass spectrometry (site mapping), co-IP, ChIP, cell-based transcription assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis and multiple orthogonal cellular assays","pmids":["21726816"],"is_preprint":false},{"year":2011,"finding":"Free (non-chromatin-associated) nuclear MSL complex binds spliced, polyadenylated msl2 mRNA, suggesting a feedback mechanism where excess MSL complex titrates newly transcribed msl2 mRNA to regulate the amount of available MSL complex.","method":"RNA immunoprecipitation, ChIP, biochemical fractionation","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP/RIP experiment with model proposal, single lab","pmids":["21551218"],"is_preprint":false},{"year":2012,"finding":"MSL2 is an E3 ubiquitin ligase that auto-ubiquitylates itself and ubiquitylates other MSL complex components (including MSL1, with sites mapped by mass spectrometry) when their stoichiometry is unbalanced, targeting them for proteasomal degradation. This provides homeostatic control of MSL complex levels.","method":"In vitro ubiquitylation assay, mass spectrometry (modification site mapping), proteasome inhibitor experiments, chromatin interaction assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro enzymatic assay, MS site mapping, and cellular functional validation","pmids":["23084834"],"is_preprint":false},{"year":2012,"finding":"The CXC domain of MSL2 adopts a solution structure with an unusual Zn3Cys9 cluster (three zinc ions coordinated by six terminal and three bridging cysteines), determined by NMR. This domain shows unexpected structural homology to pre-SET motifs of histone lysine methyltransferases.","method":"NMR spectroscopy, 1H-113Cd correlation experiments for metal-cysteine connectivity","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 — NMR structure determination with metal coordination mapping","pmids":["23029009"],"is_preprint":false},{"year":2013,"finding":"SXL promotes nuclear retention of msl2 mRNA via a third mechanism (in addition to splicing inhibition and translational repression): SXL recruits the STAR protein HOW to the msl2 5' UTR, and HOW is required for nuclear retention of msl2 transcripts but not for splicing or translational repression.","method":"GRAB purification (GST pulldown + RNA affinity), co-immunoprecipitation, reporter assays, RNAi depletion, nuclear fractionation","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — novel purification method plus multiple functional assays with RNAi","pmids":["23788626"],"is_preprint":false},{"year":2013,"finding":"hMSL2 functions in the vertebrate DNA damage response: Msl2-/- chicken cells and hMSL2-depleted human cells show defects in non-homologous end joining (NHEJ). hMSL2 is stabilized after DNA damage, and mediates ubiquitylation of 53BP1 at K1690. hMSL1 and hMOF are also modified in the presence of hMSL2 after DNA damage.","method":"Gene disruption in DT40 cells, DNA repair assays (NHEJ), immunoblotting, biochemical chromatin analysis, RNAi in human cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, but single lab with limited mechanistic depth on 53BP1 ubiquitylation","pmids":["23874665"],"is_preprint":false},{"year":2014,"finding":"The CXC domain of MSL2 specifically recognizes the MRE (MSL recognition element) motif on the X chromosome. Crystal structure of the CXC domain bound to specific and nonspecific DNAs shows the domain contacts one strand of the DNA duplex and uses a single arginine to read out dinucleotide sequences from the minor groove. The MRE core harbors two binding sites on opposite strands that cooperatively recruit a CXC dimer. Specific DNA-binding mutants are impaired in MRE binding and X chromosome localization in vivo.","method":"Crystal structure determination, in vitro DNA-binding assays, mutagenesis, in vivo localization","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with mutagenesis and in vivo functional validation","pmids":["25452275"],"is_preprint":false},{"year":2017,"finding":"Human MSL2 maintains HBV covalently closed circular DNA (cccDNA) stability by ubiquitylating and degrading APOBEC3B in hepatoma cells. HBV X protein (HBx) upregulates MSL2 expression through activation of YAP/FoxA1 signaling acting on the MSL2 promoter.","method":"Co-IP/ubiquitylation assays, siRNA knockdown, luciferase reporter assays, ChIP, xenograft tumor assays","journal":"Hepatology","confidence":"Medium","confidence_rationale":"Tier 2-3 — ubiquitylation and promoter assays in cellular model, single lab","pmids":["28608964"],"is_preprint":false},{"year":2018,"finding":"Hrp48 is a SXL co-factor that binds the 3' UTR of msl-2 and is required for optimal translational repression by SXL. Hrp48 interacts with eIF3d, a subunit of the eIF3 translation initiation complex; eIF3d binds the msl-2 5' UTR and is required for efficient translation and translational repression of msl-2. eIF3d depletion (but not other eIF3 subunits) de-represses msl-2 in female flies, consistent with Hrp48 inhibiting translation by targeting eIF3d.","method":"Co-IP, RNA chromatography, reporter assays, RNAi in cells and in vivo","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods with in vivo validation","pmids":["29635389"],"is_preprint":false},{"year":2019,"finding":"MSL2 ubiquitylation of H2B depends on substrate configuration: MSL1/2 efficiently ubiquitylates free histone substrates but very poorly modifies intact nucleosomes, implying a requirement for nucleosomal structural alteration for efficient H2B K34 ubiquitylation in vivo. MSL1/2 can deposit two ubiquitin moieties per nucleosome.","method":"In vitro ubiquitylation assays with purified MSL1/MSL2, nucleosome gel-mobility shift assay, various histone substrates","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution but single lab, limited to substrate configuration analysis","pmids":["30930284"],"is_preprint":false},{"year":2019,"finding":"MSL2 interacts directly with CLAMP through a conserved domain (CBD, clamp-binding domain) in MSL2 and the N-terminal zinc-finger domain of CLAMP. Inactivation of either the CBD or CXC domain individually only modestly affects DCC recruitment to the X chromosome, but combining both lesions in the same MSL2 mutant causes markedly increased loss of DCC recruitment, demonstrating redundancy between CLAMP-interaction and DNA-binding for DCC targeting.","method":"Genetic epistasis (double mutant), in vivo DCC localization assays, two-hybrid/binding assays","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with double mutant analysis and direct localization readout","pmids":["31320325"],"is_preprint":false},{"year":2020,"finding":"The low-complexity C-terminal domain (CTD) of MSL2 and roX non-coding RNAs form a stably condensed compartment that is the primary determinant for X chromosome-specific compartmentalization in Drosophila. Replacing the CTD of mammalian MSL2 with that from Drosophila and expressing roX in cis is sufficient to nucleate ectopic dosage compensation in mammalian cells, demonstrating that roX RNA nucleation by the MSL2 CTD drives X chromosome compartmentalization.","method":"In vivo functional assays in Drosophila and mammalian cells, domain-swap experiments, condensate/phase separation assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in two biological systems with domain-swap functional validation","pmids":["33208948"],"is_preprint":false},{"year":2022,"finding":"The intrinsically disordered region of MSL2 directly interacts with the N-terminal C2H2 zinc-finger domain of CLAMP. NMR structure of the CLAMP N-terminal C2H2 zinc finger reveals a classic fold with an unusual distribution of DNA-recognition residues. The MSL2 interaction region is conserved only within Drosophila, indicating this interaction evolved specifically for DCC recruitment.","method":"NMR structure determination, interaction mapping, mutagenesis, viability assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with mutagenesis and in vivo functional validation","pmids":["35648444"],"is_preprint":false},{"year":2023,"finding":"Cooperative binding of MSL2 and CLAMP to MRE (MSL recognition element) sites requires direct physical interaction between the two proteins; disruption of this interaction converts cooperativity to competition at composite binding sites. Cooperativity occurs largely at individual MRE level and is not influenced by MRE clustering or arrangement.","method":"Reconstituted chromatin binding assays, mutational analysis of protein-protein interface, CUT&RUN","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution in embryonic chromatin with mechanistic dissection of cooperativity vs. competition","pmids":["37602401"],"is_preprint":false},{"year":2024,"finding":"The B-domain of MSL2 destabilizes the MSL2 protein through ubiquitylation of two lysines controlled by its own RING domain. The unstructured proline-rich P-domain stimulates transcription of the roX2 gene, which is necessary for effective formation of the dosage compensation complex.","method":"Domain deletion analysis, protein stability assays, roX2 transcription reporter assays","journal":"Biochemistry. Biokhimiia","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional domain dissection in vivo, single lab","pmids":["38831503"],"is_preprint":false},{"year":2024,"finding":"Hrp48 binds a specific sequence in the msl-2 3' UTR independently of SXL and UNR, downstream of their binding sites. NMR spectroscopy and ITC defined the exact Hrp48-binding region. Hrp48 further stabilizes RNA-bound SXL indirectly via ATP-independent RNA remodeling.","method":"NMR spectroscopy, isothermal titration calorimetry, molecular dynamics simulations, translation assays","journal":"Biophysical chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with biophysical binding measurements and translation assays","pmids":["39504588"],"is_preprint":false},{"year":2025,"finding":"Single-molecule fluorescence microscopy of msl-2 mRNP assembly showed: SXL targets msl-2 mRNA via sliding and double-binding; Unr recruitment is accelerated >500-fold by RNA-bound SXL; Hrp48 stabilizes RNA-bound SXL indirectly via ATP-independent RNA remodeling, synergistically achieving tight translational repression.","method":"Multi-color single-molecule fluorescence microscopy, real-time mRNP assembly tracking","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 method — single-molecule reconstitution, but preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.04.07.647595"],"is_preprint":true}],"current_model":"MSL2 is a RING-finger/CXC-domain protein that serves as the male-specific organizer of the Drosophila dosage compensation complex (DCC): its RING finger nucleates complex assembly by directly binding MSL1 (which scaffolds MSL2, MSL3, and MLE), its CXC domain binds MRE DNA sequences in the minor groove to target the DCC to X-chromosomal high-affinity sites, and its low-complexity CTD cooperates with roX lncRNAs to form a condensed X-chromosomal compartment; additionally, MSL2 acts as an E3 ubiquitin ligase that ubiquitylates H2B K34 (promoting H3 K4/K79 methylation in trans), auto-ubiquitylates itself and partner MSL proteins for homeostatic proteasomal control, and in mammals ubiquitylates 53BP1 and APOBEC3B; in females, MSL2 production is suppressed at the levels of splicing (SXL blocks U1 and U2AF binding), nuclear mRNA export (SXL–HOW retain msl2 mRNA in the nucleus), and translation initiation (SXL, together with UNR, Hrp48, and PABP, prevents 40S ribosomal subunit association)."},"narrative":{"teleology":[{"year":1995,"claim":"Identifying MSL2 as the limiting, sex-specific organizer of the DCC answered how the dosage compensation machinery is restricted to males and how the complex assembles on the X chromosome.","evidence":"Co-IP from male larval extracts, ectopic MSL2 expression in females driving DCC assembly on female X chromosomes, immunolocalization on polytene chromosomes","pmids":["7781064","7588059","8562424"],"confidence":"High","gaps":["Mechanism of X-chromosomal targeting not yet defined","Direct interaction surfaces between MSL2 and other MSL subunits unknown"]},{"year":1998,"claim":"Demonstrating that the MSL2 RING finger directly binds MSL1 and that point mutations disrupt this interaction and male viability established the molecular basis for DCC nucleation.","evidence":"Yeast two-hybrid, Co-IP, chromatographic co-fractionation, site-directed mutagenesis of RING finger zinc-binding residues","pmids":["9736618"],"confidence":"High","gaps":["Structural basis of the RING–MSL1 interface not resolved at atomic level","How roX RNAs contribute to complex maturation unknown"]},{"year":1999,"claim":"Reconstituting SXL-mediated splicing inhibition and translational repression of msl-2 in vitro revealed the dual UTR mechanism that silences MSL2 in females: SXL blocks U2AF at the 3' splice site and prevents 40S ribosomal subunit recruitment via both UTRs.","evidence":"In vitro splicing assays with UV crosslinking and splice-site mutagenesis; cell-free Drosophila embryo translation system","pmids":["10617208","10545124"],"confidence":"High","gaps":["Trans-acting co-repressors recruited by SXL not yet identified","Mechanism of 5' UTR-mediated repression unclear"]},{"year":2003,"claim":"Pinpointing that SXL prevents stable 40S subunit association with msl-2 mRNA defined the precise step of translation initiation that is blocked, and identification of SXL's repressor domain showed it recruits co-repressors to the 3' UTR.","evidence":"Ribosome association assays on sucrose gradients, tethering assays, UV-crosslinking","pmids":["12769862","14532129"],"confidence":"High","gaps":["Identity of 3' UTR co-repressor proteins unknown","Contribution of 5' UTR intron retention versus translational repression not quantified in vivo"]},{"year":2006,"claim":"Identifying UNR as a SXL-recruited co-repressor at the msl-2 3' UTR resolved how a ubiquitous protein acquires sex-specific function and provided the first trans-acting partner in the translational silencing complex.","evidence":"mRNP purification with mass spectrometry, Co-IP, RNAi depletion, reporter assays","pmids":["16452508"],"confidence":"High","gaps":["How UNR mechanistically inhibits ribosome recruitment unknown","Whether additional co-repressors participate not yet tested"]},{"year":2007,"claim":"Domain dissection of MSL2 in vivo revealed that the RING finger suffices for chromocenter binding while the C-terminal proline-rich/basic region is required for X-chromosomal spreading and roX RNA incorporation, separating DCC assembly from targeting.","evidence":"GFP-fusion domain deletions with polytene chromosome localization","pmids":["18086881"],"confidence":"High","gaps":["Whether the C-terminal domain contacts DNA directly unknown","How roX RNA incorporation changes binding specificity not mechanistically resolved"]},{"year":2009,"claim":"Demonstrating that the SXL–UNR complex operates through PABP to block ribosome recruitment after eIF4E/G loading completed the mechanistic pathway of 3' UTR-mediated translational repression of msl-2.","evidence":"Reconstituted in vitro translation with PABP interaction assays and ribosome recruitment biochemistry","pmids":["19941818"],"confidence":"High","gaps":["Role of the poly(A) tail in 5' UTR-mediated repression not addressed","Structural basis of SXL–UNR–PABP ternary complex unknown"]},{"year":2010,"claim":"Establishing that the CXC domain directly binds DNA with low nanomolar affinity and is required for faithful X-chromosomal targeting provided the first evidence that MSL2 itself is a sequence-specific DNA-binding factor.","evidence":"Recombinant CXC domain DNA-binding assays, in vivo reporter and GFP localization","pmids":["20139418"],"confidence":"High","gaps":["Target sequence specificity not defined","Structure of CXC–DNA complex unknown"]},{"year":2011,"claim":"Discovering that human MSL1/MSL2 ubiquitylates H2B at K34 and that this mark stimulates H3 K4/K79 methylation extended MSL2 function from a structural organizer to an enzymatic writer of a histone crosstalk pathway conserved from flies to mammals.","evidence":"In vitro nucleosomal ubiquitylation, mass spectrometry site mapping, ChIP and transcription assays at HOXA9/MEIS1","pmids":["21726816"],"confidence":"High","gaps":["In vivo genome-wide distribution of H2B K34ub not mapped","Whether H2B K34ub is essential for dosage compensation not tested"]},{"year":2012,"claim":"Showing that MSL2 auto-ubiquitylates and ubiquitylates excess MSL1 for proteasomal degradation revealed a homeostatic quality-control mechanism that maintains correct DCC stoichiometry, and the NMR structure of the CXC domain uncovered an unusual Zn3Cys9 cluster with pre-SET homology.","evidence":"In vitro ubiquitylation with MS site mapping and proteasome inhibitor experiments; NMR structure of CXC domain","pmids":["23084834","23029009"],"confidence":"High","gaps":["Whether ubiquitylation-mediated turnover is regulated during development unknown","CXC–DNA recognition mode not yet structurally resolved"]},{"year":2013,"claim":"Identification of SXL–HOW-mediated nuclear retention of msl-2 mRNA established a third layer of female-specific repression beyond splicing and translation, and a role for mammalian MSL2 in NHEJ via 53BP1 ubiquitylation broadened MSL2 function to the DNA damage response.","evidence":"GRAB purification/RNAi/nuclear fractionation for HOW; DT40 KO and human RNAi for NHEJ","pmids":["23788626","23874665"],"confidence":"High","gaps":["How HOW nuclear retention intersects with splicing and translation repression quantitatively unknown","53BP1 K1690 ubiquitylation not validated by structural or reconstitution approaches"]},{"year":2014,"claim":"The crystal structure of the CXC domain bound to DNA showed that a single arginine reads MRE dinucleotide sequences from the minor groove and that the MRE core contains two binding sites on opposite strands that cooperatively recruit a CXC dimer, providing the atomic mechanism for X-chromosomal recognition.","evidence":"Crystal structures of CXC–DNA complexes (specific and nonspecific), mutagenesis, in vivo localization","pmids":["25452275"],"confidence":"High","gaps":["How CXC dimer cooperativity integrates with MSL1 scaffolding and roX RNA in full DCC not known","Contribution of non-MRE binding sites to spreading not addressed"]},{"year":2019,"claim":"Demonstrating that MSL2 and CLAMP bind MREs cooperatively through a direct physical interaction — and that disrupting this converts cooperativity to competition — revealed a redundant, two-factor recognition logic for DCC targeting to the X chromosome.","evidence":"Genetic double-mutant epistasis (CBD + CXC), reconstituted chromatin binding, CUT&RUN","pmids":["31320325","37602401"],"confidence":"High","gaps":["Structural basis of MSL2–CLAMP cooperative DNA binding not resolved","Whether CLAMP cooperativity operates at all genomic MREs or a subset unknown"]},{"year":2020,"claim":"Showing that the MSL2 low-complexity CTD and roX lncRNAs together form a condensed compartment sufficient to drive X-chromosome-specific compartmentalization — even when ectopically transferred to mammalian cells — established phase-separation-like principles as the basis for chromosome-wide dosage compensation.","evidence":"Domain-swap experiments between Drosophila and mammalian MSL2 in both systems, condensate/phase-separation assays","pmids":["33208948"],"confidence":"High","gaps":["Whether the CTD–roX compartment exhibits liquid-liquid phase separation properties in vivo not formally tested","How condensation integrates with gene-level transcriptional output unknown"]},{"year":2024,"claim":"Structural and biophysical characterization of Hrp48 binding to the msl-2 3' UTR defined the full four-factor repressor assembly (SXL–UNR–Hrp48–PABP), while domain analysis showed the MSL2 B-domain promotes auto-degradation and the P-domain stimulates roX2 transcription.","evidence":"NMR/ITC for Hrp48–RNA interface; domain deletion and stability assays for B-/P-domains","pmids":["39504588","38831503"],"confidence":"High","gaps":["How Hrp48-mediated SXL stabilization operates at the structural level unknown","Relative contribution of B-domain auto-degradation versus chromatin-level homeostasis not quantified"]},{"year":null,"claim":"Open questions remain regarding how MSL2's enzymatic (H2B K34ub), DNA-binding (CXC), CLAMP-cooperative, and condensation (CTD–roX) activities are coordinated in real time during DCC assembly and spreading along the X chromosome, and whether mammalian MSL2 functions primarily as a histone ubiquitin ligase or retains a chromosome-scale organizational role.","evidence":"","pmids":[],"confidence":"Low","gaps":["No time-resolved in vivo reconstitution of full DCC assembly exists","Mammalian MSL2 chromatin targets beyond HOXA9/MEIS1 not comprehensively mapped","Structural model of full DCC on chromatin not available"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[16,18,21,23,25]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[15,19,22,29]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[16,18,25]}],"localization":[{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[0,2,11,13,22,27]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,11,17]}],"pathway":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[15,22]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[16,18,25]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[11,16,27]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[21]}],"complexes":["Drosophila dosage compensation complex (MSL/DCC)","MSL1/MSL2 E3 ubiquitin ligase complex"],"partners":["MSL1","CLAMP","MSL3","MLE","MOF","SXL","UNR","HRP48"],"other_free_text":[]},"mechanistic_narrative":"MSL2 is the organizing subunit of the Drosophila dosage compensation complex (DCC), integrating RING-finger E3 ubiquitin ligase activity, CXC-domain DNA recognition, and lncRNA-dependent chromatin compartmentalization to achieve twofold transcriptional upregulation of the male X chromosome. Its RING finger directly binds MSL1 to nucleate DCC assembly [PMID:9736618], while its CXC domain recognizes MRE motifs through minor-groove contacts by a single arginine, cooperatively recruiting a CXC dimer together with the pioneer factor CLAMP [PMID:25452275, PMID:37602401]; its low-complexity C-terminal domain cooperates with roX lncRNAs to form a condensed X-chromosomal compartment [PMID:33208948]. MSL2 also functions as an E3 ligase that ubiquitylates histone H2B at K34 (stimulating H3 K4/K79 methylation in trans), auto-ubiquitylates itself and MSL partners for proteasomal homeostasis, and in mammals ubiquitylates 53BP1 and APOBEC3B [PMID:21726816, PMID:23084834, PMID:23874665]. In females, MSL2 production is suppressed at three post-transcriptional levels — SXL blocks splicing by preventing U1 and U2AF recruitment, SXL–HOW retain msl2 mRNA in the nucleus, and SXL together with UNR, Hrp48, and PABP prevents 40S ribosomal subunit association — ensuring sex-specific dosage compensation [PMID:10617208, PMID:23788626, PMID:19941818, PMID:39504588]."},"prefetch_data":{"uniprot":{"accession":"Q9HCI7","full_name":"E3 ubiquitin-protein ligase MSL2","aliases":["Male-specific lethal 2-like 1","MSL2-like 1","Male-specific lethal-2 homolog","MSL-2","Male-specific lethal-2 homolog 1","RING finger protein 184"],"length_aa":577,"mass_kda":62.5,"function":"Non-catalytic component of the MSL histone acetyltransferase complex, a multiprotein complex that mediates the majority of histone H4 acetylation at 'Lys-16' (H4K16ac), an epigenetic mark that prevents chromatin compaction (PubMed:16543150, PubMed:33837287). The MSL complex is required for chromosome stability and genome integrity by maintaining homeostatic levels of H4K16ac (PubMed:33837287). The MSL complex is also involved in gene dosage by promoting up-regulation of genes expressed by the X chromosome (By similarity). X up-regulation is required to compensate for autosomal biallelic expression (By similarity). The MSL complex also participates in gene dosage compensation by promoting expression of Tsix non-coding RNA (By similarity). MSL2 plays a key role in gene dosage by ensuring biallelic expression of a subset of dosage-sensitive genes, including many haploinsufficient genes (By similarity). Acts by promoting promoter-enhancer contacts, thereby preventing DNA methylation of one allele and creating a methylation-free environment for methylation-sensitive transcription factors such as SP1, KANSL1 and KANSL3 (By similarity). Also acts as an E3 ubiquitin ligase that promotes monoubiquitination of histone H2B at 'Lys-35' (H2BK34Ub), but not that of H2A (PubMed:21726816, PubMed:30930284). This activity is greatly enhanced by heterodimerization with MSL1 (PubMed:21726816, PubMed:30930284). H2B ubiquitination in turn stimulates histone H3 methylation at 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) and leads to gene activation, including that of HOXA9 and MEIS1 (PubMed:21726816). Also involved in the DNA damage response by mediating ubiquitination of TP53/p53 and TP53BP1 (PubMed:19033443, PubMed:23874665)","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q9HCI7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MSL2","classification":"Not Classified","n_dependent_lines":28,"n_total_lines":1208,"dependency_fraction":0.023178807947019868},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"YY1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/MSL2","total_profiled":1310},"omim":[{"mim_id":"620985","title":"KARAYOL-BORROTO-HAGHSHENAS NEURODEVELOPMENTAL SYNDROME; KBHS","url":"https://www.omim.org/entry/620985"},{"mim_id":"617283","title":"YTH DOMAIN-CONTAINING PROTEIN 1; YTHDC1","url":"https://www.omim.org/entry/617283"},{"mim_id":"614802","title":"MSL COMPLEX SUBUNIT 2; MSL2","url":"https://www.omim.org/entry/614802"},{"mim_id":"614801","title":"MSL COMPLEX SUBUNIT 1; MSL1","url":"https://www.omim.org/entry/614801"},{"mim_id":"609912","title":"LYSINE ACETYLTRANSFERASE 8; KAT8","url":"https://www.omim.org/entry/609912"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":58.7}],"url":"https://www.proteinatlas.org/search/MSL2"},"hgnc":{"alias_symbol":["FLJ10546","KIAA1585","msl-2"],"prev_symbol":["RNF184","MSL2L1"]},"alphafold":{"accession":"Q9HCI7","domains":[{"cath_id":"3.30.40.10","chopping":"3-136","consensus_level":"high","plddt":90.3705,"start":3,"end":136},{"cath_id":"-","chopping":"472-510","consensus_level":"medium","plddt":82.3682,"start":472,"end":510}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HCI7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCI7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCI7-F1-predicted_aligned_error_v6.png","plddt_mean":55.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MSL2","jax_strain_url":"https://www.jax.org/strain/search?query=MSL2"},"sequence":{"accession":"Q9HCI7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9HCI7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9HCI7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HCI7"}},"corpus_meta":[{"pmid":"7781064","id":"PMC_7781064","title":"Expression of msl-2 causes assembly of dosage compensation regulators on the X chromosomes and female lethality in Drosophila.","date":"1995","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/7781064","citation_count":273,"is_preprint":false},{"pmid":"10617208","id":"PMC_10617208","title":"Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3' splice site AG.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10617208","citation_count":247,"is_preprint":false},{"pmid":"9182767","id":"PMC_9182767","title":"The regulation of the Drosophila msl-2 gene reveals a function for Sex-lethal in translational control.","date":"1997","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9182767","citation_count":177,"is_preprint":false},{"pmid":"7588059","id":"PMC_7588059","title":"The msl-2 dosage compensation gene of Drosophila encodes a putative DNA-binding protein whose expression is sex specifically regulated by Sex-lethal.","date":"1995","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7588059","citation_count":144,"is_preprint":false},{"pmid":"21726816","id":"PMC_21726816","title":"The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21726816","citation_count":132,"is_preprint":false},{"pmid":"10545124","id":"PMC_10545124","title":"Translational control of dosage compensation in Drosophila by Sex-lethal: cooperative silencing via the 5' and 3' UTRs of msl-2 mRNA is independent of the poly(A) tail.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10545124","citation_count":115,"is_preprint":false},{"pmid":"9736618","id":"PMC_9736618","title":"Complex formation by the Drosophila MSL proteins: role of the MSL2 RING finger in protein complex assembly.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9736618","citation_count":106,"is_preprint":false},{"pmid":"16452508","id":"PMC_16452508","title":"Sex-lethal imparts a sex-specific function to UNR by recruiting it to the msl-2 mRNA 3' UTR: translational repression for dosage compensation.","date":"2006","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/16452508","citation_count":76,"is_preprint":false},{"pmid":"28608964","id":"PMC_28608964","title":"Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.","date":"2017","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/28608964","citation_count":64,"is_preprint":false},{"pmid":"8562424","id":"PMC_8562424","title":"The dosage compensation regulators MLE, MSL-1 and MSL-2 are interdependent since early embryogenesis in Drosophila.","date":"1995","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/8562424","citation_count":64,"is_preprint":false},{"pmid":"19941818","id":"PMC_19941818","title":"The SXL-UNR corepressor complex uses a PABP-mediated mechanism to inhibit ribosome recruitment to msl-2 mRNA.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19941818","citation_count":62,"is_preprint":false},{"pmid":"12769862","id":"PMC_12769862","title":"Drosophila sex-lethal inhibits the stable association of the 40S ribosomal subunit with msl-2 mRNA.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12769862","citation_count":60,"is_preprint":false},{"pmid":"20139418","id":"PMC_20139418","title":"The DNA binding CXC domain of MSL2 is required for faithful targeting the Dosage Compensation Complex to the X chromosome.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20139418","citation_count":59,"is_preprint":false},{"pmid":"18086881","id":"PMC_18086881","title":"Incorporation of the noncoding roX RNAs alters the chromatin-binding specificity of the Drosophila MSL1/MSL2 complex.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18086881","citation_count":48,"is_preprint":false},{"pmid":"16199870","id":"PMC_16199870","title":"The amino-terminal region of Drosophila MSL1 contains basic, glycine-rich, and leucine zipper-like motifs that promote X chromosome binding, self-association, and MSL2 binding, respectively.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16199870","citation_count":47,"is_preprint":false},{"pmid":"14532129","id":"PMC_14532129","title":"A co-repressor assembly nucleated by Sex-lethal in the 3'UTR mediates translational control of Drosophila msl-2 mRNA.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14532129","citation_count":44,"is_preprint":false},{"pmid":"33208948","id":"PMC_33208948","title":"RNA nucleation by MSL2 induces selective X chromosome compartmentalization.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33208948","citation_count":39,"is_preprint":false},{"pmid":"16179989","id":"PMC_16179989","title":"Stable chromosomal association of MSL2 defines a dosage-compensated nuclear compartment.","date":"2005","source":"Chromosoma","url":"https://pubmed.ncbi.nlm.nih.gov/16179989","citation_count":33,"is_preprint":false},{"pmid":"23084834","id":"PMC_23084834","title":"MSL2 combines sensor and effector functions in homeostatic control of the Drosophila dosage compensation machinery.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/23084834","citation_count":29,"is_preprint":false},{"pmid":"11565743","id":"PMC_11565743","title":"Modulation of msl-2 5' splice site recognition by Sex-lethal.","date":"2001","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11565743","citation_count":29,"is_preprint":false},{"pmid":"30362606","id":"PMC_30362606","title":"The long noncoding RNA MALAT-1 functions as a competing endogenous RNA to regulate MSL2 expression by sponging miR-338-3p in myasthenia gravis.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30362606","citation_count":29,"is_preprint":false},{"pmid":"25452275","id":"PMC_25452275","title":"Structural basis of X chromosome DNA recognition by the MSL2 CXC domain during Drosophila dosage compensation.","date":"2014","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/25452275","citation_count":26,"is_preprint":false},{"pmid":"6818105","id":"PMC_6818105","title":"Studies on the sex-specific lethals of Drosophila melanogaster. V. Sex transformation caused by interactions between a female-specific lethal, Sxlf 1, and the male-specific lethals mle(3)132, msl-2(27), and mle.","date":"1982","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/6818105","citation_count":20,"is_preprint":false},{"pmid":"23788626","id":"PMC_23788626","title":"Sex-lethal promotes nuclear retention of msl2 mRNA via interactions with the STAR protein HOW.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23788626","citation_count":19,"is_preprint":false},{"pmid":"31245767","id":"PMC_31245767","title":"Genetic and physical interactions between the organellar mechanosensitive ion channel homologs MSL1, MSL2, and MSL3 reveal a role for inter-organellar communication in plant development.","date":"2019","source":"Plant direct","url":"https://pubmed.ncbi.nlm.nih.gov/31245767","citation_count":19,"is_preprint":false},{"pmid":"29635389","id":"PMC_29635389","title":"Hrp48 and eIF3d contribute to msl-2 mRNA translational repression.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29635389","citation_count":18,"is_preprint":false},{"pmid":"23029009","id":"PMC_23029009","title":"Solution structure of MSL2 CXC domain reveals an unusual Zn3Cys9 cluster and similarity to pre-SET domains of histone lysine methyltransferases.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23029009","citation_count":18,"is_preprint":false},{"pmid":"6818104","id":"PMC_6818104","title":"Studies on the sex-specific lethals of Drosophila melanogaster. IV. Gynandromorph analysis of three male-specific lethals, mle, msl-2(27) and mle(3)132.","date":"1982","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/6818104","citation_count":18,"is_preprint":false},{"pmid":"21551218","id":"PMC_21551218","title":"msl2 mRNA is bound by free nuclear MSL complex in Drosophila melanogaster.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21551218","citation_count":17,"is_preprint":false},{"pmid":"8817458","id":"PMC_8817458","title":"Dosage compensation in Drosophila: the X chromosome binding of MSL-1 and MSL-2 in female embryos is prevented by the early expression of the Sxl gene.","date":"1996","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/8817458","citation_count":17,"is_preprint":false},{"pmid":"31320325","id":"PMC_31320325","title":"The simultaneous interaction of MSL2 with CLAMP and DNA provides redundancy in the initiation of dosage compensation in Drosophila males.","date":"2019","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31320325","citation_count":15,"is_preprint":false},{"pmid":"35648444","id":"PMC_35648444","title":"Structural basis for interaction between CLAMP and MSL2 proteins involved in the specific recruitment of the dosage compensation complex in Drosophila.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/35648444","citation_count":10,"is_preprint":false},{"pmid":"32446394","id":"PMC_32446394","title":"IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32446394","citation_count":9,"is_preprint":false},{"pmid":"38815585","id":"PMC_38815585","title":"MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature.","date":"2024","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38815585","citation_count":8,"is_preprint":false},{"pmid":"31612010","id":"PMC_31612010","title":"Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31612010","citation_count":8,"is_preprint":false},{"pmid":"37602401","id":"PMC_37602401","title":"Physical interaction between MSL2 and CLAMP assures direct cooperativity and prevents competition at composite binding sites.","date":"2023","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/37602401","citation_count":7,"is_preprint":false},{"pmid":"23874665","id":"PMC_23874665","title":"Msl2 is a novel component of the vertebrate DNA damage response.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23874665","citation_count":6,"is_preprint":false},{"pmid":"25737812","id":"PMC_25737812","title":"X-to-autosome expression and msl-2 transcript abundance correlate among Drosophila melanogaster somatic tissues.","date":"2015","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/25737812","citation_count":6,"is_preprint":false},{"pmid":"39504588","id":"PMC_39504588","title":"The Drosophila RNA binding protein Hrp48 binds a specific RNA sequence of the msl-2 mRNA 3' UTR to regulate translation.","date":"2024","source":"Biophysical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39504588","citation_count":5,"is_preprint":false},{"pmid":"38702431","id":"PMC_38702431","title":"Novel protein-truncating variants of a chromatin-modifying gene MSL2 in syndromic neurodevelopmental disorders.","date":"2024","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/38702431","citation_count":4,"is_preprint":false},{"pmid":"30930284","id":"PMC_30930284","title":"Analysis of histone ubiquitylation by MSL1/MSL2 proteins in vitro.","date":"2019","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/30930284","citation_count":4,"is_preprint":false},{"pmid":"34899909","id":"PMC_34899909","title":"In Hepatocellular Carcinoma, miRNA-296-3p Targets MSL2 and Suppresses Cell Proliferation and Invasion.","date":"2021","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34899909","citation_count":4,"is_preprint":false},{"pmid":"38831503","id":"PMC_38831503","title":"Functional Role of C-terminal Domains in the MSL2 Protein of Drosophila melanogaster.","date":"2024","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/38831503","citation_count":1,"is_preprint":false},{"pmid":"40954079","id":"PMC_40954079","title":"Prenatal Diagnosis of MSL2-Related Ventriculomegaly in Association With an Inherited 15q13 Microduplication.","date":"2025","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40954079","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.07.647595","title":"Real-time tracking of mRNP complex assembly reveals various mechanisms that synergistically enhance translation repression","date":"2025-04-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.07.647595","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19557,"output_tokens":7489,"usd":0.085503},"stage2":{"model":"claude-opus-4-6","input_tokens":11221,"output_tokens":3879,"usd":0.22962},"total_usd":0.315123,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"MSL2 (male-specific lethal-2) is a RING finger protein required for X chromosome dosage compensation in Drosophila males; it colocalizes with other MSL proteins on the male X chromosome and coimmunoprecipitates with MSL1 from male larval extracts, indicating it forms a dosage compensation protein complex. Ectopic expression of MSL2 in females causes assembly of the other MSL proteins on female X chromosomes, demonstrating MSL2 is the limiting/organizing subunit.\",\n      \"method\": \"Coimmunoprecipitation, ectopic expression in females, immunolocalization on polytene chromosomes\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP and functional ectopic expression, replicated across multiple labs\",\n      \"pmids\": [\"7781064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"MSL2 protein is not produced in females; sex-specific regulation is mediated through sequences in both the 5' and 3' UTRs of msl-2 mRNA, and msl-2 pre-mRNA is alternatively spliced in a Sex-lethal (SXL)-dependent fashion in its 5' UTR. MSL2 binding to the X chromosome requires the other three MSL proteins.\",\n      \"method\": \"Molecular cloning, reporter assays, polytene chromosome immunostaining in msl mutants\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, replicated by other labs\",\n      \"pmids\": [\"7588059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"MSL2, MSL1, and MLE are interdependent for sub-nuclear (X chromosome) localization beginning in early embryogenesis; loss of any one MSL protein abolishes the co-localization of the others and of histone H4Ac16 on the male X.\",\n      \"method\": \"Immunofluorescence on embryos, genetic loss-of-function\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined cellular phenotype, replicated\",\n      \"pmids\": [\"8562424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"SXL represses MSL2 protein production in females by acting synergistically through sequences in both the 5' and 3' UTRs of msl-2 mRNA, operating directly at the level of translation (not merely splicing).\",\n      \"method\": \"Reporter assays in vivo, genetic epistasis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo reporter assays with UTR deletions, replicated by other groups\",\n      \"pmids\": [\"9182767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MSL1, MSL2, and MSL3 associate in a complex (by co-immunoprecipitation and chromatography); MSL2 interacts directly with MSL1 through residues clustered around the first zinc-binding site of the RING finger domain. Missense mutations in this region disrupt MSL2–MSL1 interaction and fail to support male viability. The MSL2 RING finger nucleates MSL complex assembly; MLE is only weakly/transiently associated.\",\n      \"method\": \"Yeast two-hybrid, Co-IP, chromatographic co-fractionation, site-directed mutagenesis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including mutagenesis, in vitro and in vivo validation\",\n      \"pmids\": [\"9736618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SXL inhibits msl-2 splicing by binding the polypyrimidine tract of the regulated intron's 3' splice site, blocking U2AF65 binding and U2 snRNP recruitment. An unusually long distance between the poly(Y) tract and the AG dinucleotide is required. U2AF35 contacts the AG dinucleotide and stabilizes U2AF65 binding, and SXL can only displace U2AF65 when this U2AF35–AG interaction is weak.\",\n      \"method\": \"In vitro splicing assays, UV crosslinking, mutational analysis of splice sites\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro splicing with biochemical dissection, replicated\",\n      \"pmids\": [\"10617208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SXL-mediated translational repression of msl-2 mRNA requires cooperation between SXL-binding sites in both the 5' and 3' UTRs and occurs by a poly(A) tail-independent mechanism, as demonstrated in a cell-free Drosophila embryo translation system.\",\n      \"method\": \"Cell-free translation system from Drosophila embryos, mutational analysis of UTRs\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro translation system with mechanistic dissection\",\n      \"pmids\": [\"10545124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SXL inhibits msl-2 5' splice site recognition by binding a uridine-rich sequence downstream of the 5' splice site, preventing TIA-1 binding to that sequence and thereby blocking U1 snRNP recruitment. Combined with 3' splice site inhibition, SXL enforces intron retention via dual-site blockade.\",\n      \"method\": \"Psoralen crosslinking, in vitro splicing assays, UV-crosslinking, mutational analysis\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with biochemical mechanistic dissection\",\n      \"pmids\": [\"11565743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SXL inhibits msl-2 mRNA translation initiation by preventing the stable association of the 40S ribosomal subunit with the mRNA; this requires SXL binding to both 5' and 3' UTRs and does not require a cap structure at the 5' end.\",\n      \"method\": \"In vitro translation assays, ribosome association assays (sucrose gradient), mutational analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with defined biochemical readout\",\n      \"pmids\": [\"12769862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SXL acts as a translational repressor through its two RRM domains and a C-terminal heptapeptide extension; its repressor function is activated only when SXL binds msl-2 mRNA via its own RRMs. SXL recruits co-repressor proteins to the msl-2 3' UTR via sequences adjacent to its binding sites, and this requires an intact repressor domain.\",\n      \"method\": \"In vitro translation assays, UV-crosslinking, co-immunoprecipitation, tethering assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple biochemical methods with mutational dissection\",\n      \"pmids\": [\"14532129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The N-terminal leucine zipper-like motif of MSL1 directly binds MSL2, and the basic motif at the MSL1 N-terminus is required for X chromosome binding. A glycine-rich region mediates MSL1 self-association and association with the MSL complex assembled on the X chromosome.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding, polytene chromosome immunostaining in mutants\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal binding assays combined with in vivo genetic validation\",\n      \"pmids\": [\"16199870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MSL2 is stably (essentially immobile) associated with the X chromosome during interphase, as measured by photobleaching (FRAP) in living cells. Knockdown of MSL2 abolishes H4K16 acetylation and the twofold transcriptional elevation of the male X chromosome. Targeting MSL2 to a reporter gene is sufficient to initiate local dosage compensation.\",\n      \"method\": \"FRAP in living cells, RNAi knockdown, reporter gene tethering, transcription assays\",\n      \"journal\": \"Chromosoma\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct FRAP localization with functional consequence, RNAi phenotype\",\n      \"pmids\": [\"16179989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SXL recruits UNR (upstream of N-ras) to the msl-2 mRNA 3' UTR as a co-repressor; UNR is required for 3' UTR-mediated translational repression of msl-2, and SXL confers a female-specific function to the otherwise ubiquitous UNR protein.\",\n      \"method\": \"mRNP purification (mass spectrometry), co-immunoprecipitation, functional reporter assays, RNAi depletion\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — purification/MS identification with functional validation by RNAi\",\n      \"pmids\": [\"16452508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The N-terminal RING finger domain of MSL2, in complex with MSL1, binds to the heterochromatic chromocenter and a few chromosomal arm sites. The carboxyl-terminal domain of MSL2 (proline-rich and basic motifs) is required for binding to hundreds of X-chromosomal sites and for efficient incorporation of roX RNAs into the MSL complex. Incorporation of roX RNAs alters the chromatin-binding specificity of the MSL1/MSL2 complex.\",\n      \"method\": \"GFP-fusion protein localization, domain deletion analysis, polytene chromosome immunostaining\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic domain dissection with direct localization readout in vivo\",\n      \"pmids\": [\"18086881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The SXL–UNR co-repressor complex inhibits ribosome recruitment to msl-2 mRNA via a PABP (poly(A)-binding protein)-dependent mechanism: efficient 3' UTR-mediated repression requires a poly(A) tail and PABP function, UNR directly interacts with PABP, and the repressor complex targets ribosome binding after PABP-mediated recruitment of eIF4E/G.\",\n      \"method\": \"In vitro translation assays, ribosome recruitment biochemical assays, protein-protein interaction assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with mechanistic dissection of translation initiation steps\",\n      \"pmids\": [\"19941818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The CXC domain of MSL2 directly binds DNA with low nanomolar affinity in vitro. In vivo, the CXC domain is required for faithful targeting of the dosage compensation complex to the X chromosome; deletion of the CXC domain impairs DCC targeting in reporter assays and GFP-fusion localization experiments.\",\n      \"method\": \"Recombinant protein DNA-binding assay, reporter gene assay in vivo, GFP-fusion localization\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro biochemical DNA binding combined with in vivo functional validation\",\n      \"pmids\": [\"20139418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Human MSL2, together with MSL1, functions as a histone E3 ubiquitin ligase that ubiquitylates nucleosomal H2B specifically on lysine 34 (H2B K34ub). H2B K34ub by MSL1/2 directly stimulates H3 K4 and K79 methylation through trans-tail crosstalk in vitro and in cells. This activity is important for transcription activation at HOXA9 and MEIS1 loci and is evolutionarily conserved in Drosophila.\",\n      \"method\": \"In vitro ubiquitylation assay with reconstituted nucleosomes, mass spectrometry (site mapping), co-IP, ChIP, cell-based transcription assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis and multiple orthogonal cellular assays\",\n      \"pmids\": [\"21726816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Free (non-chromatin-associated) nuclear MSL complex binds spliced, polyadenylated msl2 mRNA, suggesting a feedback mechanism where excess MSL complex titrates newly transcribed msl2 mRNA to regulate the amount of available MSL complex.\",\n      \"method\": \"RNA immunoprecipitation, ChIP, biochemical fractionation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP/RIP experiment with model proposal, single lab\",\n      \"pmids\": [\"21551218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MSL2 is an E3 ubiquitin ligase that auto-ubiquitylates itself and ubiquitylates other MSL complex components (including MSL1, with sites mapped by mass spectrometry) when their stoichiometry is unbalanced, targeting them for proteasomal degradation. This provides homeostatic control of MSL complex levels.\",\n      \"method\": \"In vitro ubiquitylation assay, mass spectrometry (modification site mapping), proteasome inhibitor experiments, chromatin interaction assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro enzymatic assay, MS site mapping, and cellular functional validation\",\n      \"pmids\": [\"23084834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The CXC domain of MSL2 adopts a solution structure with an unusual Zn3Cys9 cluster (three zinc ions coordinated by six terminal and three bridging cysteines), determined by NMR. This domain shows unexpected structural homology to pre-SET motifs of histone lysine methyltransferases.\",\n      \"method\": \"NMR spectroscopy, 1H-113Cd correlation experiments for metal-cysteine connectivity\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure determination with metal coordination mapping\",\n      \"pmids\": [\"23029009\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SXL promotes nuclear retention of msl2 mRNA via a third mechanism (in addition to splicing inhibition and translational repression): SXL recruits the STAR protein HOW to the msl2 5' UTR, and HOW is required for nuclear retention of msl2 transcripts but not for splicing or translational repression.\",\n      \"method\": \"GRAB purification (GST pulldown + RNA affinity), co-immunoprecipitation, reporter assays, RNAi depletion, nuclear fractionation\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — novel purification method plus multiple functional assays with RNAi\",\n      \"pmids\": [\"23788626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"hMSL2 functions in the vertebrate DNA damage response: Msl2-/- chicken cells and hMSL2-depleted human cells show defects in non-homologous end joining (NHEJ). hMSL2 is stabilized after DNA damage, and mediates ubiquitylation of 53BP1 at K1690. hMSL1 and hMOF are also modified in the presence of hMSL2 after DNA damage.\",\n      \"method\": \"Gene disruption in DT40 cells, DNA repair assays (NHEJ), immunoblotting, biochemical chromatin analysis, RNAi in human cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, but single lab with limited mechanistic depth on 53BP1 ubiquitylation\",\n      \"pmids\": [\"23874665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The CXC domain of MSL2 specifically recognizes the MRE (MSL recognition element) motif on the X chromosome. Crystal structure of the CXC domain bound to specific and nonspecific DNAs shows the domain contacts one strand of the DNA duplex and uses a single arginine to read out dinucleotide sequences from the minor groove. The MRE core harbors two binding sites on opposite strands that cooperatively recruit a CXC dimer. Specific DNA-binding mutants are impaired in MRE binding and X chromosome localization in vivo.\",\n      \"method\": \"Crystal structure determination, in vitro DNA-binding assays, mutagenesis, in vivo localization\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis and in vivo functional validation\",\n      \"pmids\": [\"25452275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Human MSL2 maintains HBV covalently closed circular DNA (cccDNA) stability by ubiquitylating and degrading APOBEC3B in hepatoma cells. HBV X protein (HBx) upregulates MSL2 expression through activation of YAP/FoxA1 signaling acting on the MSL2 promoter.\",\n      \"method\": \"Co-IP/ubiquitylation assays, siRNA knockdown, luciferase reporter assays, ChIP, xenograft tumor assays\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ubiquitylation and promoter assays in cellular model, single lab\",\n      \"pmids\": [\"28608964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Hrp48 is a SXL co-factor that binds the 3' UTR of msl-2 and is required for optimal translational repression by SXL. Hrp48 interacts with eIF3d, a subunit of the eIF3 translation initiation complex; eIF3d binds the msl-2 5' UTR and is required for efficient translation and translational repression of msl-2. eIF3d depletion (but not other eIF3 subunits) de-represses msl-2 in female flies, consistent with Hrp48 inhibiting translation by targeting eIF3d.\",\n      \"method\": \"Co-IP, RNA chromatography, reporter assays, RNAi in cells and in vivo\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with in vivo validation\",\n      \"pmids\": [\"29635389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MSL2 ubiquitylation of H2B depends on substrate configuration: MSL1/2 efficiently ubiquitylates free histone substrates but very poorly modifies intact nucleosomes, implying a requirement for nucleosomal structural alteration for efficient H2B K34 ubiquitylation in vivo. MSL1/2 can deposit two ubiquitin moieties per nucleosome.\",\n      \"method\": \"In vitro ubiquitylation assays with purified MSL1/MSL2, nucleosome gel-mobility shift assay, various histone substrates\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution but single lab, limited to substrate configuration analysis\",\n      \"pmids\": [\"30930284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MSL2 interacts directly with CLAMP through a conserved domain (CBD, clamp-binding domain) in MSL2 and the N-terminal zinc-finger domain of CLAMP. Inactivation of either the CBD or CXC domain individually only modestly affects DCC recruitment to the X chromosome, but combining both lesions in the same MSL2 mutant causes markedly increased loss of DCC recruitment, demonstrating redundancy between CLAMP-interaction and DNA-binding for DCC targeting.\",\n      \"method\": \"Genetic epistasis (double mutant), in vivo DCC localization assays, two-hybrid/binding assays\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double mutant analysis and direct localization readout\",\n      \"pmids\": [\"31320325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The low-complexity C-terminal domain (CTD) of MSL2 and roX non-coding RNAs form a stably condensed compartment that is the primary determinant for X chromosome-specific compartmentalization in Drosophila. Replacing the CTD of mammalian MSL2 with that from Drosophila and expressing roX in cis is sufficient to nucleate ectopic dosage compensation in mammalian cells, demonstrating that roX RNA nucleation by the MSL2 CTD drives X chromosome compartmentalization.\",\n      \"method\": \"In vivo functional assays in Drosophila and mammalian cells, domain-swap experiments, condensate/phase separation assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in two biological systems with domain-swap functional validation\",\n      \"pmids\": [\"33208948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The intrinsically disordered region of MSL2 directly interacts with the N-terminal C2H2 zinc-finger domain of CLAMP. NMR structure of the CLAMP N-terminal C2H2 zinc finger reveals a classic fold with an unusual distribution of DNA-recognition residues. The MSL2 interaction region is conserved only within Drosophila, indicating this interaction evolved specifically for DCC recruitment.\",\n      \"method\": \"NMR structure determination, interaction mapping, mutagenesis, viability assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with mutagenesis and in vivo functional validation\",\n      \"pmids\": [\"35648444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cooperative binding of MSL2 and CLAMP to MRE (MSL recognition element) sites requires direct physical interaction between the two proteins; disruption of this interaction converts cooperativity to competition at composite binding sites. Cooperativity occurs largely at individual MRE level and is not influenced by MRE clustering or arrangement.\",\n      \"method\": \"Reconstituted chromatin binding assays, mutational analysis of protein-protein interface, CUT&RUN\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution in embryonic chromatin with mechanistic dissection of cooperativity vs. competition\",\n      \"pmids\": [\"37602401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The B-domain of MSL2 destabilizes the MSL2 protein through ubiquitylation of two lysines controlled by its own RING domain. The unstructured proline-rich P-domain stimulates transcription of the roX2 gene, which is necessary for effective formation of the dosage compensation complex.\",\n      \"method\": \"Domain deletion analysis, protein stability assays, roX2 transcription reporter assays\",\n      \"journal\": \"Biochemistry. Biokhimiia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional domain dissection in vivo, single lab\",\n      \"pmids\": [\"38831503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Hrp48 binds a specific sequence in the msl-2 3' UTR independently of SXL and UNR, downstream of their binding sites. NMR spectroscopy and ITC defined the exact Hrp48-binding region. Hrp48 further stabilizes RNA-bound SXL indirectly via ATP-independent RNA remodeling.\",\n      \"method\": \"NMR spectroscopy, isothermal titration calorimetry, molecular dynamics simulations, translation assays\",\n      \"journal\": \"Biophysical chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with biophysical binding measurements and translation assays\",\n      \"pmids\": [\"39504588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Single-molecule fluorescence microscopy of msl-2 mRNP assembly showed: SXL targets msl-2 mRNA via sliding and double-binding; Unr recruitment is accelerated >500-fold by RNA-bound SXL; Hrp48 stabilizes RNA-bound SXL indirectly via ATP-independent RNA remodeling, synergistically achieving tight translational repression.\",\n      \"method\": \"Multi-color single-molecule fluorescence microscopy, real-time mRNP assembly tracking\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 method — single-molecule reconstitution, but preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.04.07.647595\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"MSL2 is a RING-finger/CXC-domain protein that serves as the male-specific organizer of the Drosophila dosage compensation complex (DCC): its RING finger nucleates complex assembly by directly binding MSL1 (which scaffolds MSL2, MSL3, and MLE), its CXC domain binds MRE DNA sequences in the minor groove to target the DCC to X-chromosomal high-affinity sites, and its low-complexity CTD cooperates with roX lncRNAs to form a condensed X-chromosomal compartment; additionally, MSL2 acts as an E3 ubiquitin ligase that ubiquitylates H2B K34 (promoting H3 K4/K79 methylation in trans), auto-ubiquitylates itself and partner MSL proteins for homeostatic proteasomal control, and in mammals ubiquitylates 53BP1 and APOBEC3B; in females, MSL2 production is suppressed at the levels of splicing (SXL blocks U1 and U2AF binding), nuclear mRNA export (SXL–HOW retain msl2 mRNA in the nucleus), and translation initiation (SXL, together with UNR, Hrp48, and PABP, prevents 40S ribosomal subunit association).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MSL2 is the organizing subunit of the Drosophila dosage compensation complex (DCC), integrating RING-finger E3 ubiquitin ligase activity, CXC-domain DNA recognition, and lncRNA-dependent chromatin compartmentalization to achieve twofold transcriptional upregulation of the male X chromosome. Its RING finger directly binds MSL1 to nucleate DCC assembly [PMID:9736618], while its CXC domain recognizes MRE motifs through minor-groove contacts by a single arginine, cooperatively recruiting a CXC dimer together with the pioneer factor CLAMP [PMID:25452275, PMID:37602401]; its low-complexity C-terminal domain cooperates with roX lncRNAs to form a condensed X-chromosomal compartment [PMID:33208948]. MSL2 also functions as an E3 ligase that ubiquitylates histone H2B at K34 (stimulating H3 K4/K79 methylation in trans), auto-ubiquitylates itself and MSL partners for proteasomal homeostasis, and in mammals ubiquitylates 53BP1 and APOBEC3B [PMID:21726816, PMID:23084834, PMID:23874665]. In females, MSL2 production is suppressed at three post-transcriptional levels — SXL blocks splicing by preventing U1 and U2AF recruitment, SXL–HOW retain msl2 mRNA in the nucleus, and SXL together with UNR, Hrp48, and PABP prevents 40S ribosomal subunit association — ensuring sex-specific dosage compensation [PMID:10617208, PMID:23788626, PMID:19941818, PMID:39504588].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Identifying MSL2 as the limiting, sex-specific organizer of the DCC answered how the dosage compensation machinery is restricted to males and how the complex assembles on the X chromosome.\",\n      \"evidence\": \"Co-IP from male larval extracts, ectopic MSL2 expression in females driving DCC assembly on female X chromosomes, immunolocalization on polytene chromosomes\",\n      \"pmids\": [\"7781064\", \"7588059\", \"8562424\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of X-chromosomal targeting not yet defined\", \"Direct interaction surfaces between MSL2 and other MSL subunits unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that the MSL2 RING finger directly binds MSL1 and that point mutations disrupt this interaction and male viability established the molecular basis for DCC nucleation.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, chromatographic co-fractionation, site-directed mutagenesis of RING finger zinc-binding residues\",\n      \"pmids\": [\"9736618\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the RING–MSL1 interface not resolved at atomic level\", \"How roX RNAs contribute to complex maturation unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Reconstituting SXL-mediated splicing inhibition and translational repression of msl-2 in vitro revealed the dual UTR mechanism that silences MSL2 in females: SXL blocks U2AF at the 3' splice site and prevents 40S ribosomal subunit recruitment via both UTRs.\",\n      \"evidence\": \"In vitro splicing assays with UV crosslinking and splice-site mutagenesis; cell-free Drosophila embryo translation system\",\n      \"pmids\": [\"10617208\", \"10545124\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting co-repressors recruited by SXL not yet identified\", \"Mechanism of 5' UTR-mediated repression unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Pinpointing that SXL prevents stable 40S subunit association with msl-2 mRNA defined the precise step of translation initiation that is blocked, and identification of SXL's repressor domain showed it recruits co-repressors to the 3' UTR.\",\n      \"evidence\": \"Ribosome association assays on sucrose gradients, tethering assays, UV-crosslinking\",\n      \"pmids\": [\"12769862\", \"14532129\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of 3' UTR co-repressor proteins unknown\", \"Contribution of 5' UTR intron retention versus translational repression not quantified in vivo\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying UNR as a SXL-recruited co-repressor at the msl-2 3' UTR resolved how a ubiquitous protein acquires sex-specific function and provided the first trans-acting partner in the translational silencing complex.\",\n      \"evidence\": \"mRNP purification with mass spectrometry, Co-IP, RNAi depletion, reporter assays\",\n      \"pmids\": [\"16452508\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How UNR mechanistically inhibits ribosome recruitment unknown\", \"Whether additional co-repressors participate not yet tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Domain dissection of MSL2 in vivo revealed that the RING finger suffices for chromocenter binding while the C-terminal proline-rich/basic region is required for X-chromosomal spreading and roX RNA incorporation, separating DCC assembly from targeting.\",\n      \"evidence\": \"GFP-fusion domain deletions with polytene chromosome localization\",\n      \"pmids\": [\"18086881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the C-terminal domain contacts DNA directly unknown\", \"How roX RNA incorporation changes binding specificity not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating that the SXL–UNR complex operates through PABP to block ribosome recruitment after eIF4E/G loading completed the mechanistic pathway of 3' UTR-mediated translational repression of msl-2.\",\n      \"evidence\": \"Reconstituted in vitro translation with PABP interaction assays and ribosome recruitment biochemistry\",\n      \"pmids\": [\"19941818\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of the poly(A) tail in 5' UTR-mediated repression not addressed\", \"Structural basis of SXL–UNR–PABP ternary complex unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing that the CXC domain directly binds DNA with low nanomolar affinity and is required for faithful X-chromosomal targeting provided the first evidence that MSL2 itself is a sequence-specific DNA-binding factor.\",\n      \"evidence\": \"Recombinant CXC domain DNA-binding assays, in vivo reporter and GFP localization\",\n      \"pmids\": [\"20139418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target sequence specificity not defined\", \"Structure of CXC–DNA complex unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovering that human MSL1/MSL2 ubiquitylates H2B at K34 and that this mark stimulates H3 K4/K79 methylation extended MSL2 function from a structural organizer to an enzymatic writer of a histone crosstalk pathway conserved from flies to mammals.\",\n      \"evidence\": \"In vitro nucleosomal ubiquitylation, mass spectrometry site mapping, ChIP and transcription assays at HOXA9/MEIS1\",\n      \"pmids\": [\"21726816\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo genome-wide distribution of H2B K34ub not mapped\", \"Whether H2B K34ub is essential for dosage compensation not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showing that MSL2 auto-ubiquitylates and ubiquitylates excess MSL1 for proteasomal degradation revealed a homeostatic quality-control mechanism that maintains correct DCC stoichiometry, and the NMR structure of the CXC domain uncovered an unusual Zn3Cys9 cluster with pre-SET homology.\",\n      \"evidence\": \"In vitro ubiquitylation with MS site mapping and proteasome inhibitor experiments; NMR structure of CXC domain\",\n      \"pmids\": [\"23084834\", \"23029009\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ubiquitylation-mediated turnover is regulated during development unknown\", \"CXC–DNA recognition mode not yet structurally resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of SXL–HOW-mediated nuclear retention of msl-2 mRNA established a third layer of female-specific repression beyond splicing and translation, and a role for mammalian MSL2 in NHEJ via 53BP1 ubiquitylation broadened MSL2 function to the DNA damage response.\",\n      \"evidence\": \"GRAB purification/RNAi/nuclear fractionation for HOW; DT40 KO and human RNAi for NHEJ\",\n      \"pmids\": [\"23788626\", \"23874665\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HOW nuclear retention intersects with splicing and translation repression quantitatively unknown\", \"53BP1 K1690 ubiquitylation not validated by structural or reconstitution approaches\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The crystal structure of the CXC domain bound to DNA showed that a single arginine reads MRE dinucleotide sequences from the minor groove and that the MRE core contains two binding sites on opposite strands that cooperatively recruit a CXC dimer, providing the atomic mechanism for X-chromosomal recognition.\",\n      \"evidence\": \"Crystal structures of CXC–DNA complexes (specific and nonspecific), mutagenesis, in vivo localization\",\n      \"pmids\": [\"25452275\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CXC dimer cooperativity integrates with MSL1 scaffolding and roX RNA in full DCC not known\", \"Contribution of non-MRE binding sites to spreading not addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that MSL2 and CLAMP bind MREs cooperatively through a direct physical interaction — and that disrupting this converts cooperativity to competition — revealed a redundant, two-factor recognition logic for DCC targeting to the X chromosome.\",\n      \"evidence\": \"Genetic double-mutant epistasis (CBD + CXC), reconstituted chromatin binding, CUT&RUN\",\n      \"pmids\": [\"31320325\", \"37602401\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of MSL2–CLAMP cooperative DNA binding not resolved\", \"Whether CLAMP cooperativity operates at all genomic MREs or a subset unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showing that the MSL2 low-complexity CTD and roX lncRNAs together form a condensed compartment sufficient to drive X-chromosome-specific compartmentalization — even when ectopically transferred to mammalian cells — established phase-separation-like principles as the basis for chromosome-wide dosage compensation.\",\n      \"evidence\": \"Domain-swap experiments between Drosophila and mammalian MSL2 in both systems, condensate/phase-separation assays\",\n      \"pmids\": [\"33208948\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the CTD–roX compartment exhibits liquid-liquid phase separation properties in vivo not formally tested\", \"How condensation integrates with gene-level transcriptional output unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Structural and biophysical characterization of Hrp48 binding to the msl-2 3' UTR defined the full four-factor repressor assembly (SXL–UNR–Hrp48–PABP), while domain analysis showed the MSL2 B-domain promotes auto-degradation and the P-domain stimulates roX2 transcription.\",\n      \"evidence\": \"NMR/ITC for Hrp48–RNA interface; domain deletion and stability assays for B-/P-domains\",\n      \"pmids\": [\"39504588\", \"38831503\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Hrp48-mediated SXL stabilization operates at the structural level unknown\", \"Relative contribution of B-domain auto-degradation versus chromatin-level homeostasis not quantified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Open questions remain regarding how MSL2's enzymatic (H2B K34ub), DNA-binding (CXC), CLAMP-cooperative, and condensation (CTD–roX) activities are coordinated in real time during DCC assembly and spreading along the X chromosome, and whether mammalian MSL2 functions primarily as a histone ubiquitin ligase or retains a chromosome-scale organizational role.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No time-resolved in vivo reconstitution of full DCC assembly exists\", \"Mammalian MSL2 chromatin targets beyond HOXA9/MEIS1 not comprehensively mapped\", \"Structural model of full DCC on chromatin not available\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [16, 18, 21, 23, 25]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [15, 19, 22, 29]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [16, 18, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 2, 11, 13, 22, 27]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 11, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [15, 22]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [16, 18, 25]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [11, 16, 27]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"complexes\": [\n      \"Drosophila dosage compensation complex (MSL/DCC)\",\n      \"MSL1/MSL2 E3 ubiquitin ligase complex\"\n    ],\n    \"partners\": [\n      \"MSL1\",\n      \"CLAMP\",\n      \"MSL3\",\n      \"MLE\",\n      \"MOF\",\n      \"SXL\",\n      \"UNR\",\n      \"Hrp48\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}